Shandong Weigao Group Medical Polymer Company Limited provided earnings guidance for the year ended 31 December 2023. For the year, the company expects to record a decrease in revenue in the range of 2% to 5% during the Reporting Period as compared with the revenue recognised due to the accounting restatement as a result of business combination under common control for the same period last year; and a decrease of net profit attributable to the owners of the Company for the Reporting Period in the range of 25% to 30% as compared with the Net Profit reported with consideration of the accounting restatement as a result of business combination under common control for the same period last year.
Shandong Weigao Group Medical Polymer Company Limited
Equities
1066
CNE100000171
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.34 HKD | +2.69% | +10.10% | -29.83% |
Mar. 26 | Shandong Weigao Group Medical Polymer Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 11 | Weigao Orthopaedic Device's Chairman Resigns | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.83% | 3.12B | |
+8.34% | 27.27B | |
-15.97% | 2.53B | |
+18.11% | 2.47B | |
+3.70% | 2B | |
-9.47% | 1.91B | |
-2.22% | 1.48B | |
+2.78% | 1.3B | |
+18.92% | 1.18B | |
+3.72% | 1.13B |
- Stock Market
- Equities
- 1066 Stock
- News Shandong Weigao Group Medical Polymer Company Limited
- Shandong Weigao Group Medical Polymer Company Limited Provides Earnings Guidance for the Year Ended 31 December 2023